Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-20-000102.pdf
0001558370-20-000102.rtf
0001558370-20-000102.xls
EX-101.SCH - EX-101.SCH
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-20-000431.pdf
0001179110-20-000431.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-20-000074.pdf
0001558370-20-000074.rtf
0001558370-20-000074.xls
EX-101.SCH - EX-101.SCH
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-19-013128.pdf
0001179110-19-013128.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-19-011670.pdf
0001558370-19-011670.rtf
0001558370-19-011670.xls
EX-101.SCH - EX-101.SCH
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-19-013033.pdf
0001179110-19-013033.rtf
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-19-012998.pdf
0001179110-19-012998.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-19-011419.pdf
0001558370-19-011419.rtf
0001558370-19-011419.xls
EX-101.SCH - EX-101.SCH
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-19-012511.pdf
0001179110-19-012511.rtf
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-19-011918.pdf
0001179110-19-011918.rtf